GlaxoSmithKline (GSK) has announced it is to axe 55 jobs at its Montrose site in Angus, with a further 70 temporary roles set to be phased out during the remainder of the year.
The move comes as part of the pharmaceutical giant’s aim to save £700 million per year by 2010.
“We have to remain competitive and the proposals represent the best route for the future of the Montrose site and for GSK overall,” said site director Alan Catterall.
“The position the site finds itself in is not a reflection of the performance of staff at Montrose, who have shown the highest levels of professionalism, achieving every milestone and target over the last 18 months.
“It is a reflection of the fiercely competitive nature of the marketplace for our products and the need for GSK to respond to this difficult environment.”
